Verifying the effectiveness of medical abortion; ultrasound versus hCG testing

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 109, Issue 2, 2003, Pages 190-195

  Fiala, Christian ^a,b   Safar, Peter ^a   Bygdeman, Marc ^b   Gemzell Danielsson, Kristina ^b  

^a Department of Surgery   (Austria)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

hCG; Medical abortion; Mifepristone; Ultrasound; Verification of expulsion

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; AMENORRHEA; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; RELIABILITY; TREATMENT OUTCOME; ULTRASOUND;

EID: 0038648317     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00012-5     Document Type: Article

References (13)

1. Aubeny E., Peyron R., Turpin C.L., Renault M., Targosz V., Silvestre L.et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol (corrected). Int. J. Fertil. Menopausal Stud. 40(Suppl 2):1995;85-91.
2. Aubeny E. Trends since 1989, in France, of induced abortions by mifepristone (RU486) combined with a prostaglandin analogue. Contracept. Fertil. Sex. 25:1997;777-781.
3. Peyron R., Aubeny E., Targosz V., Silvestre L., Renault M., Elkik F.et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N. Engl. J. Med. 328:1993;1509-1513.
4. Winikoff B., Ellertson C., Elul B., Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone clinical trials group. Arch. Fam. Med. 7:1998;360-366.
5. WHO. Medical Methods For Termination Of Pregnancy. 1997.
6. Spitz I.M., Bardin C.W., Benton L., Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N. Engl. J. Med. 338:1998;1241-1247.
7. Bygdeman M, Gemzell-Danielsson K, Marions L. Medical termination of early pregnancy: the Swedish experience. J Am Med Womens Assoc 2000;55:195-6204.
8. Jourdan MC v d B M. Intert des beta HCG dans. 1991.
9. Creinin M.D., Spitz I.M. Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion. Am. J. Obstet. Gynecol. 181:1999;1419-1424.
10. Robinson H.P., Fleming J.E. A critical evaluation of sonar crown-length measurements. Br. J. Obstet. Gynaecol. 82:1975;702-710.
11. Chervenak F.A., Brightman R.C., Thornton J., Berkowitz G.S., David S. Crown-rump length and serum human chorionic gonadotropin as predictors of gestational age. Obstet. Gynecol. 67:1986;210-213.
12. el-Refaey H., Rajasekar D., Abdalla M., Calder L., Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N. Engl. J. Med. 332:1995;983-987.
13. Tang O.S., Gao P.P., Cheng L., Lee S.W., Ho P.C. A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol. Hum. Reprod. 14:1999;722-725.